Revolade NZ CMI

website revolade Revolade is indicated in adult patients with chronic hepatitis C virus infection for the treatment of thrombocytopenia, where the degree of revolade Revolade Active substance Eltrombopag Holder Novartis Status Closed Indication patients aged 1 year and above with primary immune thrombocytopenia

revolade Revolade Information Revolade, a prescription drug, is manufactured in various forms such as Tablet Primarily, it is used for the treatment of  Revolade is available by prescription only Date filed: Contact: Bureau of Metabolism  Revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia lasting 6 months or longer from

Share

Share

Link

Turn off sharing Copy link

See all details